Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF; Infectious Diseases Society of America.

Clin Infect Dis. 2011 Feb 1;52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4. Erratum in: Clin Infect Dis. 2011 Aug 1;53(3):319.

PMID:
21208910
2.

Methicillin-resistant Staphylococcus aureus infections.

Taylor AR.

Prim Care. 2013 Sep;40(3):637-54. doi: 10.1016/j.pop.2013.06.002. Epub 2013 Jul 16. Review.

PMID:
23958361
3.

Toward the development of evidence-based guidelines for the management of methicillin-resistant Staphylococcus aureus otitis.

MacNeil SD, Westerberg BD, Romney MG.

J Otolaryngol Head Neck Surg. 2009 Aug;38(4):483-94. Review.

PMID:
19755090
4.

Diagnosis and management of community-associated MRSA infections in children.

Long CB, Madan RP, Herold BC.

Expert Rev Anti Infect Ther. 2010 Feb;8(2):183-95. doi: 10.1586/eri.09.127. Review.

PMID:
20109048
6.

Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.

Culos KA, Cannon JP, Grim SA.

Am J Ther. 2013 Mar-Apr;20(2):200-12. doi: 10.1097/MJT.0b013e31821109ec. Review.

PMID:
21642833
7.
8.

[Current view of vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections].

Martínková J.

Klin Mikrobiol Infekc Lek. 2015 Mar;21(1):16-23. Review. Czech.

PMID:
26098489
9.

Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines.

Moran GJ, Abrahamian FM, Lovecchio F, Talan DA.

J Emerg Med. 2013 Jun;44(6):e397-412. doi: 10.1016/j.jemermed.2012.11.050. Epub 2013 Mar 5. Review.

10.

A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice.

Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, Cornaglia G, Esposito S, French G, Giamarellou H, Gyssens IC, Nathwani D, Unal S, Voss A.

Clin Microbiol Infect. 2010 Mar;16 Suppl 1:3-30. doi: 10.1111/j.1469-0691.2010.03135.x. Review.

11.

Methicillin-resistant Staphylococcus aureus therapy: past, present, and future.

Rodvold KA, McConeghy KW.

Clin Infect Dis. 2014 Jan;58 Suppl 1:S20-7. doi: 10.1093/cid/cit614. Review.

PMID:
24343828
12.

[Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].

Gudiol F, Aguado JM, Pascual A, Pujol M, Almirante B, Miró JM, Cercenado E, Domínguez Mde L, Soriano A, Rodríguez-Baño J, Vallés J, Palomar M, Tornos P, Bouza E; Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.

Enferm Infecc Microbiol Clin. 2009 Feb;27(2):105-15. doi: 10.1016/j.eimc.2008.09.003. Epub 2009 Feb 11. Review. Spanish.

PMID:
19254641
13.

Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.

Schairer J, Sankri-Tarbichi AG, Fairfax MR, Salimnia H, Guzman JA.

J Intensive Care Med. 2008 Sep-Oct;23(5):338-41. doi: 10.1177/0885066608320849. Review.

PMID:
18701528
14.

Staphylococcal infections in the era of MRSA.

Jackson MA, Newland JG.

Pediatr Rev. 2011 Dec;32(12):522-32. doi: 10.1542/pir.32-12-522. Review. No abstract available.

PMID:
22135422
15.

Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus - a clinician's guide to the science informing current practice.

Lee JY, Howden BP.

Expert Rev Anti Infect Ther. 2015 Jul;13(7):855-69. doi: 10.1586/14787210.2015.1041924. Epub 2015 May 6. Review.

PMID:
25947636
16.

Diagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy.

Esposito S, Bassetti M, Borre' S, Bouza E, Dryden M, Fantoni M, Gould IM, Leoncini F, Leone S, Milkovich G, Nathwani D, Segreti J, Sganga G, Unal S, Venditti M; Italian Society of Infectious Tropical Diseases; International Society of Chemotherapy.

J Chemother. 2011 Oct;23(5):251-62. Review.

PMID:
22005055
17.

Pharmacokinetics and safety of recently approved drugs used to treat methicillin-resistant Staphylococcus aureus infections in infants, children and adults.

Gostelow M, Gonzalez D, Smith PB, Cohen-Wolkowiez M.

Expert Rev Clin Pharmacol. 2014 May;7(3):327-40. doi: 10.1586/17512433.2014.909281. Epub 2014 Apr 9. Review.

18.

Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Newland JG, Kearns GL.

Paediatr Drugs. 2008;10(6):367-78. doi: 10.2165/0148581-200810060-00004. Review.

PMID:
18998747
19.

Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?

Hazlewood KA, Brouse SD, Pitcher WD, Hall RG.

Am J Med. 2010 Feb;123(2):182.e1-7. doi: 10.1016/j.amjmed.2009.05.031. Review.

20.

Treatment of community-acquired pneumonia.

Lee YR, Houngue C, Hall RG.

Expert Rev Anti Infect Ther. 2015;13(9):1109-21. doi: 10.1586/14787210.2015.1060125. Epub 2015 Jun 19. Review.

PMID:
26091895

Supplemental Content

Support Center